FdaApplication
ANDA 217085
Identifiers
- fda_app_no: ANDA217085
Properties
| Property | Value |
|---|---|
| applicant_name | NATCO PHARMA LTD |
| application_type | ANDA |
| approval_date | 2026-06-01 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ERIBULIN MESYLATE | ERIBULIN MESYLATE | 1MG/2ML (0.5MG/ML) | SOLUTION;INTRAVENOUS |
1 product